Chronic immunosuppression does not potentiate the malignant progression of mucinous pancreatic cystic lesions

Patients with mPCLs exposed to immunosuppressive medications did not have higher rates of malignancy or development worrisome features in the short term. This suggests that patients with mPCLs can be initiated or maintained on these agents without changes to surveillance practices.